{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:18:47Z","timestamp":1790630327649,"version":"4.1.0"},"reference-count":60,"publisher":"Archives of Endocrinology and Metabolism","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,21]]},"DOI":"10.20945\/2359-3997000000300","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T16:43:01Z","timestamp":1605804181000},"source":"Crossref","is-referenced-by-count":5,"title":["Metabolomics as a potential tool for the diagnosis of growth hormone deficiency (GHD): a review"],"prefix":"10.20945","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7349-3446","authenticated-orcid":false,"given":"Breno Sena De","family":"San-Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8053-3867","authenticated-orcid":false,"given":"Vin\u00edcius Guimar\u00e3es","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6286-5558","authenticated-orcid":false,"given":"Mariana Rechia","family":"Bitencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6735-4925","authenticated-orcid":false,"given":"Paulo Cesar Gon\u00e7alves","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7351-8220","authenticated-orcid":false,"given":"Emanuel","family":"Carrilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3747-0415","authenticated-orcid":false,"given":"Nilson Ant\u00f4nio de","family":"Assun\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7313-2130","authenticated-orcid":false,"given":"Luciani Renata Silveira de","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"8510","reference":[{"issue":"1","key":"key20201119114226_B1","first-page":"75","article-title":"Metabol\u00f4mica: Defini\u00e7\u00f5es, Estado-Da-Arte E Aplica\u00e7\u00f5es Representativas","volume":"41","author":"Canuto","year":"2018","unstructured":"1. Canuto GAB, Da Costa JL, Da Cruz PLR, De Souza ARL, Faccio AT, Klassen A, et al. Metabol\u00f4mica: Defini\u00e7\u00f5es, Estado-Da-Arte E Aplica\u00e7\u00f5es Representativas. Quim Nova. 2018;41(1):75-91.","journal-title":"Quim Nova"},{"issue":"1-2","key":"key20201119114226_B2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1013713905833","article-title":"Metabolomics \u2013 The link between genotypes and phenotypes","volume":"48","author":"Fiehn","year":"2002","unstructured":"2. Fiehn O. Metabolomics \u2013 The link between genotypes and phenotypes. Plant Mol Biol. 2002;48(1-2):155-71.","journal-title":"Plant Mol Biol"},{"issue":"5258","key":"key20201119114226_B3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/227561a0","article-title":"Central dogma of molecular biology","volume":"227","author":"Crick","year":"1970","unstructured":"3. Crick F. Central dogma of molecular biology. Nature. 1970;227(5258):561-3.","journal-title":"Nature"},{"issue":"3","key":"key20201119114226_B4","first-page":"139","article-title":"Identifying epimetabolites by integrating metabolome databases with mass spectrometry cheminformatics","volume":"176","author":"Lai","year":"2019","unstructured":"4. Lai Z, Tsugawa H, Wohlgemuth G, Mehta S, Mueller M, Zheng Y, et al. Identifying epimetabolites by integrating metabolome databases with mass spectrometry cheminformatics. Physiol Behav. 2019;176(3):139-48.","journal-title":"Physiol Behav"},{"key":"key20201119114226_B5","first-page":"316","volume-title":"Nature Biotechnology","author":"Guijas","year":"2018","unstructured":"5. Guijas C, Montenegro-Burke JR, Warth B, Spilker ME, Siuzdak G. Metabolomics activity screening for identifying metabolites that modulate phenotype. Vol. 36, Nature Biotechnology. Nature Publishing Group; 2018. p. 316-20."},{"issue":"3","key":"key20201119114226_B6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1615\/CritRevBiomedEng.2013007736","article-title":"Metabolomic fingerprinting: Challenges and opportunities","volume":"41","author":"Kosmides","year":"2013","unstructured":"6. Kosmides AK, Kamisoglu K, Calvano SE, Corbett SA, Androulakis IP. Metabolomic fingerprinting: Challenges and opportunities. Crit Rev Biomed Eng. 2013;41(3):205-21.","journal-title":"Crit Rev Biomed Eng"},{"issue":"1","key":"key20201119114226_B7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-015-0661-3","article-title":"Metabolomic approach to profile functional and metabolic changes in heart failure","volume":"13","author":"Deidda","year":"2015","unstructured":"7. Deidda M, Piras C, Dessalvi CC, Locci E, Barberini L, Torri F, et al. Metabolomic approach to profile functional and metabolic changes in heart failure. J Transl Med. 2015;13(1):1-11.","journal-title":"J Transl Med"},{"issue":"10","key":"key20201119114226_B8","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.3390\/ijms20102576","article-title":"The relevance of mass spectrometry analysis for personalized medicine through its successful application in cancer \u201cOmics\u201d","volume":"20","author":"Ciocan-Cartita","year":"2019","unstructured":"8. Ciocan-Cartita CA, Jurj A, Buse M, Gulei D, Braicu C, Raduly L, et al. The relevance of mass spectrometry analysis for personalized medicine through its successful application in cancer \u201cOmics\u201d. Int J Mol Sci. 2019;20(10):2576.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"key20201119114226_B9","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/mas.21455","article-title":"Mass spectrometric based approaches in urine metabolomics and biomarker discovery","volume":"36","author":"Khamis","year":"2017","unstructured":"9. Khamis MM, Adamko DJ, El-Aneed A. Mass spectrometric based approaches in urine metabolomics and biomarker discovery. Mass Spectrom Rev. 2017;36(2):115-34.","journal-title":"Mass Spectrom Rev"},{"key":"key20201119114226_B10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.chroma.2019.04.071","article-title":"Rapid liquid chromatography tandem mass spectrometry method for targeted quantitation of human performance metabolites in saliva","volume":"1601","author":"McBride","year":"2019","unstructured":"10. McBride EM, Lawrence RJ, McGee K, Mach PM, Demond PS, Busch MW, et al. Rapid liquid chromatography tandem mass spectrometry method for targeted quantitation of human performance metabolites in saliva. J Chromatogr A [Internet]. 2019;1601:205-13.","journal-title":"J Chromatogr A [Internet]"},{"issue":"1","key":"key20201119114226_B11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1039\/C7AN01571B","article-title":"Chemical analysis in saliva and the search for salivary biomarkers-a tutorial review","volume":"143","author":"Ngamchuea","year":"2018","unstructured":"11. Ngamchuea K, Chaisiwamongkhol K, Batchelor-Mcauley C, Compton RG. Chemical analysis in saliva and the search for salivary biomarkers-a tutorial review. Analyst. 2018;143(1):81-99.","journal-title":"Analyst"},{"issue":"15","key":"key20201119114226_B12","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1177\/2047487316645469","article-title":"Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment","volume":"23","author":"Dona","year":"2016","unstructured":"12. Dona AC, Coffey S, Figtree G. Translational and emerging clinical applications of metabolomics in cardiovascular disease diagnosis and treatment. Eur J Prev Cardiol. 2016;23(15):1578-89.","journal-title":"Eur J Prev Cardiol"},{"key":"key20201119114226_B13","article-title":"Metabolomic profiling for identification of novel potential biomarkers in cardiovascular diseases","volume":"2011","author":"Vivanco","year":"2011","unstructured":"13. Vivanco F, Barderas MG, Laborde CM, Posada M, De La Cuesta F, Zubiri I, et al. Metabolomic profiling for identification of novel potential biomarkers in cardiovascular diseases. J Biomed Biotechnol. 2011;2011(May).","journal-title":"J Biomed Biotechnol"},{"issue":"1","key":"key20201119114226_B14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cmet.2016.09.018","article-title":"Metabolomics and Metabolic Diseases: Where Do We Stand?","volume":"25","author":"Newgard","year":"2017","unstructured":"14. Newgard CB. Metabolomics and Metabolic Diseases: Where Do We Stand? Cell Metab. 2017;25(1):43-56.","journal-title":"Cell Metab"},{"issue":"10","key":"key20201119114226_B15","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.tem.2017.07.001","article-title":"Endocrinology Meets Metabolomics: Achievements, Pitfalls, and Challenges","volume":"28","author":"Tokarz","year":"2017","unstructured":"15. Tokarz J, Haid M, Cecil A, Prehn C, Artati A, M\u00f6ller G, et al. Endocrinology Meets Metabolomics: Achievements, Pitfalls, and Challenges. Trends Endocrinol Metab [Internet]. 2017;28(10):705-21.","journal-title":"Trends Endocrinol Metab [Internet]"},{"key":"key20201119114226_B16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1741-7015-10-153","article-title":"Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: Plasma metabolomics analysis","volume":"10","author":"Zhao","year":"2012","unstructured":"16. Zhao Y, Fu L, Li R, Wang LN, Yang Y, Liu NN, et al. Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: Plasma metabolomics analysis. BMC Med. 2012;10:153.","journal-title":"BMC Med"},{"issue":"2","key":"key20201119114226_B17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/EJE-16-0875","article-title":"Seven years of growth hormone (GH) replacement improves quality of life in hypopituitary patients with adult-onset GH deficiency","volume":"176","author":"Elbornsson","year":"2017","unstructured":"17. Elbornsson M, Horvath A, G\u00f6therstr\u00f6m G, Bengtsson BA, Johannsson G, Svensson J. Seven years of growth hormone (GH) replacement improves quality of life in hypopituitary patients with adult-onset GH deficiency. Eur J Endocrinol. 2017;176(2):99-109.","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"key20201119114226_B18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S2213-8587(15)00098-4","article-title":"Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: A prospective observational cohort study","volume":"3","author":"Mo","year":"2015","unstructured":"18. Mo D, Fleseriu M, Qi R, Jia N, Child CJ, Bouillon R, et al. Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: A prospective observational cohort study. Lancet Diabetes Endocrinol [Internet]. 2015;3(5):331-8.","journal-title":"Lancet Diabetes Endocrinol [Internet]"},{"issue":"11","key":"key20201119114226_B19","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: An endocrine society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","unstructured":"19. Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, Salvatori R, et al. Hormonal replacement in hypopituitarism in adults: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(11):3888-921.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key20201119114226_B20","doi-asserted-by":"crossref","first-page":"R212","DOI":"10.1530\/EC-18-0099","article-title":"The growth hormone-insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders","volume":"7","author":"Blum","year":"2018","unstructured":"20. Blum WF, Alherbish A, Alsagheir A, El Awwa A, Kaplan W, Koledova E, et al. The growth hormone-insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders. Endocr Connect. 2018;7(6):R212-22.","journal-title":"Endocr Connect"},{"issue":"26","key":"key20201119114226_B21","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1056\/NEJMra1817346","article-title":"Pathogenesis and diagnosis of growth hormone deficiency in adults","volume":"380","author":"Shlomo","year":"2019","unstructured":"21. Shlomo M. Pathogenesis and diagnosis of growth hormone deficiency in adults. N Engl J Med. 2019;380(26):2551-62.","journal-title":"N Engl J Med"},{"issue":"5","key":"key20201119114226_B22","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1210\/jcem.87.5.8509","article-title":"Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency","volume":"87","author":"Biller","year":"2002","unstructured":"22. Biller BMK, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, et al. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab. 2002;87(5):2067-79.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key20201119114226_B23","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: An endocrine society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","unstructured":"23. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML. Evaluation and treatment of adult growth hormone deficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(6):1587-609.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key20201119114226_B24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0137643","article-title":"Modified clonidine testing for growth hormone stimulation reveals \u03b12-adrenoreceptor sub sensitivity in children with idiopathic growth hormone deficiency","volume":"10","author":"Willaschek","year":"2015","unstructured":"24. Willaschek C, Meint S, Rager K, Buchhorn R. Modified clonidine testing for growth hormone stimulation reveals \u03b12-adrenoreceptor sub sensitivity in children with idiopathic growth hormone deficiency. PLoS One. 2015;10(9):1-15.","journal-title":"PLoS One"},{"issue":"1","key":"key20201119114226_B25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000502231","article-title":"Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective","volume":"92","author":"Collett-Solberg","year":"2019","unstructured":"25. Collett-Solberg PF, Ambler G, Backeljauw PF, Bidlingmaier M, Biller BMK, Boguszewski MCS, et al. Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective. Horm Res Paediatr. 2019;92(1):1-14.","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"key20201119114226_B26","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1530\/EC-14-0098","article-title":"Metabolomics: a tool for the diagnosis of GH deficiency and for monitoring GH replacement?","volume":"3","author":"H\u00f6ybye","year":"2014","unstructured":"26. H\u00f6ybye C, Wahlstr\u00f6m E, Tollet-Egnell P, Norstedt G. Metabolomics: a tool for the diagnosis of GH deficiency and for monitoring GH replacement? Endocr Connect. 2014;3(4):200-6.","journal-title":"Endocr Connect"},{"issue":"1-2","key":"key20201119114226_B27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ghir.2012.12.001","article-title":"Urine metabonomic profiling of a female adolescent with PIT-1 mutation before and during growth hormone therapy: Insights into the metabolic effects of growth hormone","volume":"23","author":"Abd Rahman","year":"2013","unstructured":"27. Abd Rahman S, Schirra HJ, Lichanska AM, Huynh T, Leong GM. Urine metabonomic profiling of a female adolescent with PIT-1 mutation before and during growth hormone therapy: Insights into the metabolic effects of growth hormone. Growth Horm IGF Res. 2013;23(1-2):29-36.","journal-title":"Growth Horm IGF Res"},{"issue":"1","key":"key20201119114226_B28","first-page":"1689","article-title":"Long-term Effects of Growth Hormone Replacement Therapy in Childhood-onset Craniopharyngioma: Results of the German Craniopharyngioma Registry (HIT-Endo)","volume":"52","author":"Soares","year":"2014","unstructured":"28. Soares DV, Concei\u00e7\u00e3o FL, Vaisman M, Kochi C, Portes ES, Jorge AADL, et al. Long-term Effects of Growth Hormone Replacement Therapy in Childhood-onset Craniopharyngioma: Results of the German Craniopharyngioma Registry (HIT-Endo). Arq Bras Endocrinol Metabol [Internet]. 2014;52(1):1689-99.","journal-title":"Arq Bras Endocrinol Metabol [Internet]"},{"issue":"22","key":"key20201119114226_B29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.6065\/apem.2017.22.3.145","article-title":"Effects of growth hormone on glucose metabolism and insulin resistance in human","volume":"1012","author":"Kim","year":"2017","unstructured":"29. Kim S, Park M-J. Effects of growth hormone on glucose metabolism and insulin resistance in human. Ann Pediatr Endocrinol Metab. 2017;1012(22):145-52.","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"7","key":"key20201119114226_B30","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.medin.2017.10.003","article-title":"Systematic review and meta-analysis","volume":"42","author":"Delgado-Rodr\u00edguez","year":"2018","unstructured":"30. Delgado-Rodr\u00edguez M, Sillero-Arenas M. Systematic review and meta-analysis. Med Intensiva. 2018 Oct 1;42(7):444-53.","journal-title":"Med Intensiva"},{"issue":"1","key":"key20201119114226_B31","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1021\/acs.analchem.5b04491","article-title":"Toward Merging Untargeted and Targeted Methods in Mass Spectrometry-Based Metabolomics and Lipidomics","volume":"88","author":"Cajka","year":"2016","unstructured":"31. Cajka T, Fiehn O. Toward Merging Untargeted and Targeted Methods in Mass Spectrometry-Based Metabolomics and Lipidomics. Anal Chem. 2016;88(1):524-45.","journal-title":"Anal Chem"},{"issue":"3","key":"key20201119114226_B32","first-page":"65","article-title":"High-Performance Liquid Chromatography-Mass Spectrometry-Based Lipid Metabolite Profiling of Acromegaly","volume":"105","author":"Richter","year":"2020","unstructured":"32. Richter J, Herzog N, Janka S, Baumann T, Kistenmacher A, Oltmanns KM. High-Performance Liquid Chromatography-Mass Spectrometry-Based Lipid Metabolite Profiling of Acromegaly. J Clin Endocrinol Metab [Internet]. 2020 Apr 1 [cited 2020 Jun 30];105(3):65-77.","journal-title":"J Clin Endocrinol Metab [Internet]"},{"issue":"11","key":"key20201119114226_B33","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrcardio.2011.138","article-title":"Metabolomics as a tool for cardiac research","volume":"8","author":"Griffin","year":"2011","unstructured":"33. Griffin JL, Atherton H, Shockcor J, Atzori L. Metabolomics as a tool for cardiac research. Nat Rev Cardiol. 2011;8(11):630-43.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"key20201119114226_B34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-018-0750-4","article-title":"Untargeted metabolomic on urine samples after \u03b1-lipoic acid and\/or eicosapentaenoic acid supplementation in healthy overweight\/obese women","volume":"17","author":"Romo-Hualde","year":"2018","unstructured":"34. Romo-Hualde A, Huerta AE, Gonz\u00e1lez-Navarro CJ, Ramos-L\u00f3pez O, Moreno-Aliaga MJ, Mart\u00ednez JA. Untargeted metabolomic on urine samples after \u03b1-lipoic acid and\/or eicosapentaenoic acid supplementation in healthy overweight\/obese women. Lipids Health Dis. 2018;17(1):1-13.","journal-title":"Lipids Health Dis"},{"key":"key20201119114226_B35","first-page":"19","volume-title":"Advances in Experimental Medicine and Biology","author":"Lynch","year":"2019","unstructured":"35. Lynch M, Ramalingam N. Integrated Fluidic Circuits for Single-Cell Omics and Multi-omics Applications. In: Advances in Experimental Medicine and Biology. Springer New York LLC; 2019. p. 19-26."},{"issue":"2","key":"key20201119114226_B36","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/BOR.0000000000000250","article-title":"Biomarkers to guide clinical therapeutics in rheumatology?","volume":"28","author":"Robinson","year":"2016","unstructured":"36. Robinson WH, Mao R. Biomarkers to guide clinical therapeutics in rheumatology? Curr Opin Rheumatol. 2016;28(2):168-75.","journal-title":"Curr Opin Rheumatol"},{"key":"key20201119114226_B37","first-page":"159","volume-title":"Dental Clinics of North America","author":"Malamud","year":"2011","unstructured":"37. Malamud D. Saliva as a Diagnostic Fluid. Vol. 55. Dental Clinics of North America. NIH Public Access; 2011. p. 159-78."},{"issue":"5","key":"key20201119114226_B38","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1007\/s11306-013-0524-y","article-title":"NMR-based metabolomics in human disease diagnosis: Applications, limitations, and recommendations","volume":"9","author":"Emwas","year":"2013","unstructured":"38. Emwas AHM, Salek RM, Griffin JL, Merzaban J. NMR-based metabolomics in human disease diagnosis: Applications, limitations, and recommendations. Metabolomics. 2013;9(5):1048-72.","journal-title":"Metabolomics"},{"issue":"1","key":"key20201119114226_B39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4155\/bio-2016-0224","article-title":"Investigation of the derivatization conditions for GC-MS metabolomics of biological samples","volume":"9","author":"Moros","year":"2017","unstructured":"39. Moros G, Chatziioannou AC, Gika HG, Raikos N, Theodoridis G. Investigation of the derivatization conditions for GC-MS metabolomics of biological samples. Bioanalysis. 2017;9(1):53-65.","journal-title":"Bioanalysis"},{"issue":"2","key":"key20201119114226_B40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/metabo10020054","article-title":"General Guidelines for Sample Preparation Strategies in HR-\u03bcMAS NMR-based Metabolomics of Microscopic Specimens","volume":"10","author":"Lucas-Torres","year":"2020","unstructured":"40. Lucas-Torres, Bernard T, Huber, Berthault, Nishiyama, Kandiyal, et al. General Guidelines for Sample Preparation Strategies in HR-\u03bcMAS NMR-based Metabolomics of Microscopic Specimens. Metabolites [Internet]. 2020;10(2):54.","journal-title":"Metabolites [Internet]"},{"issue":"4","key":"key20201119114226_B41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4322\/sc.2017.018","article-title":"Eletroforese capilar acoplada \u00e0 espectrometria de massas (CE-MS): aspectos te\u00f3ricos, pr\u00e1ticos e aplica\u00e7\u00f5es no campo da metabol\u00f4mica","volume":"9","author":"Simionato","year":"2017","unstructured":"41. Simionato AVC, Santos FN dos, Hernandes VV. Eletroforese capilar acoplada \u00e0 espectrometria de massas (CE-MS): aspectos te\u00f3ricos, pr\u00e1ticos e aplica\u00e7\u00f5es no campo da metabol\u00f4mica. Sci Chromatogr. 2017;9(4):228-44.","journal-title":"Sci Chromatogr"},{"key":"key20201119114226_B42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-1-4939-2377-9_13","article-title":"The Strengths and Weaknesses of NMR Spectroscopy and Mass Spectrometry with Particular Focus on Metabolomics Research","volume":"1277","author":"Emwas","year":"2015","unstructured":"42. Emwas A-HM. The Strengths and Weaknesses of NMR Spectroscopy and Mass Spectrometry with Particular Focus on Metabolomics Research. Methods Mol Biol. 2015;1277:161-93.","journal-title":"Methods Mol Biol"},{"issue":"23","key":"key20201119114226_B43","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1021\/ac202220b","article-title":"Liquid chromatography-high resolution mass spectrometry analysis of fatty acid metabolism","volume":"83","author":"Kamphorst","year":"2011","unstructured":"43. Kamphorst JJ, Fan J, Lu W, White E, Rabinowitz JD. Liquid chromatography-high resolution mass spectrometry analysis of fatty acid metabolism. Anal Chem. 2011;83(23):9114-22.","journal-title":"Anal Chem"},{"issue":"2","key":"key20201119114226_B44","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12020-019-02143-0","article-title":"Metabolic profiling of acromegaly using a GC\u2013MS-based nontargeted metabolomic approach","volume":"67","author":"Yu","year":"2020","unstructured":"44. Yu H, Zhao Y, Zhang Y, Zhong L. Metabolic profiling of acromegaly using a GC\u2013MS-based nontargeted metabolomic approach. Endocrine. 2020 Feb;67(2):433-41.","journal-title":"Endocrine"},{"issue":"12","key":"key20201119114226_B45","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.4155\/bio.14.119","article-title":"Analytical protocols based on LC-MS, GC-MS and CE-MS for nontargeted metabolomics of biological tissues","volume":"6","author":"Naz","year":"2014","unstructured":"45. Naz S, Moreira Dos Santos DC, Garc\u00eda A, Barbas C. Analytical protocols based on LC-MS, GC-MS and CE-MS for nontargeted metabolomics of biological tissues. Bioanalysis. 2014;6(12):1657-77.","journal-title":"Bioanalysis"},{"issue":"1","key":"key20201119114226_B46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4155\/bio-2016-0202","article-title":"Direct infusion mass spectrometry for metabolomic phenotyping of diseases","volume":"9","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2017","unstructured":"46. Gonz\u00e1lez-Dom\u00ednguez R, Sayago A, Fern\u00e1ndez-Recamales A. Direct infusion mass spectrometry for metabolomic phenotyping of diseases. Bioanalysis. 2017;9(1):131-48.","journal-title":"Bioanalysis"},{"issue":"1","key":"key20201119114226_B47","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/metabo9010012","article-title":"Direct infusion based metabolomics identifies metabolic disease in patients' dried blood spots and plasma","volume":"9","author":"Haijes","year":"2019","unstructured":"47. Haijes HA, Willemsen M, van der Ham M, Gerrits J, Pras-Raves ML, Prinsen HCMT, et al. Direct infusion based metabolomics identifies metabolic disease in patients' dried blood spots and plasma. Metabolites. 2019;9(1):12.","journal-title":"Metabolites"},{"issue":"2","key":"key20201119114226_B48","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nprot.2016.156","article-title":"A complete workflow for high-resolution spectral-stitching nanoelectrospray direct-infusion mass-spectrometry-based metabolomics and lipidomics","volume":"12","author":"Southam","year":"2017","unstructured":"48. Southam AD, Weber RJM, Engel J, Jones MR, Viant MR. A complete workflow for high-resolution spectral-stitching nanoelectrospray direct-infusion mass-spectrometry-based metabolomics and lipidomics. Nat Protoc. 2017;12(2):255-73.","journal-title":"Nat Protoc"},{"issue":"1","key":"key20201119114226_B49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13321-018-0324-5","article-title":"BioTransformer: A comprehensive computational tool for small molecule metabolism prediction and metabolite identification","volume":"11","author":"Djoumbou-Feunang","year":"2019","unstructured":"49. Djoumbou-Feunang Y, Fiamoncini J, Gil-de-la-Fuente A, Greiner R, Manach C, Wishart DS. BioTransformer: A comprehensive computational tool for small molecule metabolism prediction and metabolite identification. J Cheminform. 2019;11(1):1-25.","journal-title":"J Cheminform"},{"issue":"2","key":"key20201119114226_B50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/2213235X04666160613122429","article-title":"PCA as a predictor of OPLS-DA model reliability","volume":"4","author":"Worley","year":"2016","unstructured":"50. Worley B, Powers R. PCA as a predictor of OPLS-DA model reliability. Curr Metabolomics. 2016;4(2):97-103.","journal-title":"Curr Metabolomics"},{"issue":"W1","key":"key20201119114226_B51","doi-asserted-by":"crossref","first-page":"W486","DOI":"10.1093\/nar\/gky310","article-title":"MetaboAnalyst 4.0: Towards more transparent and integrative metabolomics analysis","volume":"46","author":"Chong","year":"2018","unstructured":"51. Chong J, Soufan O, Li C, Caraus I, Li S, Bourque G, et al. MetaboAnalyst 4.0: Towards more transparent and integrative metabolomics analysis. Nucleic Acids Res. 2018;46(W1):W486-94.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"key20201119114226_B52","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41592-018-0110-3","article-title":"XCMS-MRM and METLIN-MRM: a cloud library and public resource for targeted analysis of small molecules","volume":"15","author":"Domingo-Almenara","year":"2018","unstructured":"52. Domingo-Almenara X, Montenegro-Burke JR, Ivanisevic J, Thomas A, Sidib\u00e9 J, Teav T, et al. XCMS-MRM and METLIN-MRM: a cloud library and public resource for targeted analysis of small molecules. Nat Methods. 2018 Sep;15(9):681-4.","journal-title":"Nat Methods"},{"issue":"5","key":"key20201119114226_B53","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12859-016-1043-4","article-title":"Integration of multi-omics data for prediction of phenotypic traits using random forest","volume":"17","author":"Acharjee","year":"2016","unstructured":"53. Acharjee A, Kloosterman B, Visser RGF, Maliepaard C. Integration of multi-omics data for prediction of phenotypic traits using random forest. BMC Bioinformatics. 2016;17(5):180.","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"key20201119114226_B54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-019-1912-5","article-title":"-Omics biomarker identification pipeline for translational medicine","volume":"17","author":"Bravo-Merodio","year":"2019","unstructured":"54. Bravo-Merodio L, Williams JA, Gkoutos GV, Acharjee A. -Omics biomarker identification pipeline for translational medicine. J Transl Med. 2019;17(1):1-10.","journal-title":"J Transl Med"},{"issue":"2","key":"key20201119114226_B55","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11306-012-0482-9","article-title":"Translational biomarker discovery in clinical metabolomics: An introductory tutorial","volume":"9","author":"Xia","year":"2013","unstructured":"55. Xia J, Broadhurst DI, Wilson M, Wishart DS. Translational biomarker discovery in clinical metabolomics: An introductory tutorial. Metabolomics. 2013;9(2):280-99.","journal-title":"Metabolomics"},{"issue":"D1","key":"key20201119114226_B56","doi-asserted-by":"crossref","first-page":"D608","DOI":"10.1093\/nar\/gkx1089","article-title":"HMDB 4.0: The human metabolome database for 2018","volume":"46","author":"Wishart","year":"2018","unstructured":"56. Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, V\u00e1zquez-Fresno R, et al. HMDB 4.0: The human metabolome database for 2018. Nucleic Acids Res. 2018;46(D1):D608-17.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"key20201119114226_B57","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1021\/acs.analchem.7b04424","article-title":"METLIN: A Technology Platform for Identifying Knowns and Unknowns","volume":"90","author":"Guijas","year":"2018","unstructured":"57. Guijas C, Montenegro-Burke JR, Domingo-Almenara X, Palermo A, Warth B, Hermann G, et al. METLIN: A Technology Platform for Identifying Knowns and Unknowns. Anal Chem. 2018;90(5):3156-64.","journal-title":"Anal Chem"},{"issue":"7","key":"key20201119114226_B58","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/dta.2798","article-title":"Applying metabolomics to detect growth hormone administration in athletes: Proof of concept","volume":"12","author":"Narduzzi","year":"2020","unstructured":"58. Narduzzi L, Dervilly G, Marchand A, Audran M, Le Bizec B, Buisson C. Applying metabolomics to detect growth hormone administration in athletes: Proof of concept. Drug Test Anal. 2020 Jul;12(7):887-99.","journal-title":"Drug Test Anal"},{"issue":"6","key":"key20201119114226_B59","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1042\/CS20181005","article-title":"Metabolomic analysis reveals metabolic characteristics of children with short stature caused by growth hormone deficiency","volume":"133","author":"Xu","year":"2019","unstructured":"59. Xu R, Zhu H, Zhang C, Shen G, Feng J. Metabolomic analysis reveals metabolic characteristics of children with short stature caused by growth hormone deficiency. Clin Sci. 2019;133(6):777-88.","journal-title":"Clin Sci"},{"issue":"10","key":"key20201119114226_B60","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.3390\/jcm8101549","article-title":"Metabolic Fingerprint of Acromegaly and its Potential Usefulness in Clinical Practice","volume":"8","author":"Biagetti","year":"2019","unstructured":"60. Biagetti B, Herance JR, Ferrer R, Aulinas A, Palomino-Sch\u00e4tzlein M, Mesa J, et al. Metabolic Fingerprint of Acromegaly and its Potential Usefulness in Clinical Practice. J Clin Med. 2019;8(10):1549.","journal-title":"J Clin Med"}],"container-title":["Archives of Endocrinology and Metabolism"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T21:22:00Z","timestamp":1618435320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S2359-39972020005008203&lng=en&nrm=iso"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":60,"alternative-id":["10.20945\/2359-3997000000300"],"URL":"https:\/\/doi.org\/10.20945\/2359-3997000000300","relation":{},"ISSN":["2359-3997","2359-4292"],"issn-type":[{"value":"2359-3997","type":"print"},{"value":"2359-4292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]}}}